Terminated PHASE3 INTERVENTIONAL 3-arm NCT01071902

Safety and Efficacy of Moxidex Otic

Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Acute Otitis Media With Otorrhea in Tympanostomy Tubes

Sponsor: Alcon Research

Conditions Acute Otitis Media

Interventions Moxidex otic solution Moxifloxacin otic solution Tympanostomy tubes Vehicle

Updated 7 times since 2017 Last updated: Nov 29, 2012 Started: Feb 28, 2010 Primary completion: Oct 31, 2011 Completion: Oct 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Management decision

Other terminated trials from Alcon Research

See all terminations from Alcon Research

Other Acute Otitis Media trials with similar outcome

Browse all Acute Otitis Media trials

Listed as NCT01071902, this PHASE3 trial focuses on Acute Otitis Media and remains terminated or withdrawn. Sponsored by Alcon Research, it has been updated 7 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Apr 2022 — Jul 2024 [monthly]

Terminated PHASE3
Jan 2021 — Apr 2022 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Terminated PHASE3
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE3

First recorded

Feb 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alcon Research

Data source: Alcon Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fort Worth, United States